These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its alpha receptor. De Marchis F; Ribatti D; Giampietri C; Lentini A; Faraone D; Scoccianti M; Capogrossi MC; Facchiano A Blood; 2002 Mar; 99(6):2045-53. PubMed ID: 11877278 [TBL] [Abstract][Full Text] [Related]
4. Identification of a novel domain of fibroblast growth factor 2 controlling its angiogenic properties. Facchiano A; Russo K; Facchiano AM; De Marchis F; Facchiano F; Ribatti D; Aguzzi MS; Capogrossi MC J Biol Chem; 2003 Mar; 278(10):8751-60. PubMed ID: 12496262 [TBL] [Abstract][Full Text] [Related]
5. Heterodimerization of FGF-receptor 1 and PDGF-receptor-alpha: a novel mechanism underlying the inhibitory effect of PDGF-BB on FGF-2 in human cells. Faraone D; Aguzzi MS; Ragone G; Russo K; Capogrossi MC; Facchiano A Blood; 2006 Mar; 107(5):1896-902. PubMed ID: 16322476 [TBL] [Abstract][Full Text] [Related]
6. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways. Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904 [TBL] [Abstract][Full Text] [Related]
7. Endostar attenuates melanoma tumor growth via its interruption of b-FGF mediated angiogenesis. Xiao L; Yang S; Hao J; Yuan X; Luo W; Jiang L; Hu Y; Fu Z; Zhang Y; Zou C Cancer Lett; 2015 Apr; 359(1):148-54. PubMed ID: 25597785 [TBL] [Abstract][Full Text] [Related]
14. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis. Bai Y; Bai L; Zhou J; Chen H; Zhang L Cell Immunol; 2018 Jan; 323():19-32. PubMed ID: 29111157 [TBL] [Abstract][Full Text] [Related]
15. Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo. McGary EC; Onn A; Mills L; Heimberger A; Eton O; Thomas GW; Shtivelband M; Bar-Eli M J Invest Dermatol; 2004 Feb; 122(2):400-5. PubMed ID: 15009722 [TBL] [Abstract][Full Text] [Related]
16. RAM, an RGDS analog, exerts potent anti-melanoma effects in vitro and in vivo. Aguzzi MS; D'Arcangelo D; Giampietri C; Capogrossi MC; Facchiano A PLoS One; 2011; 6(10):e25352. PubMed ID: 21984914 [TBL] [Abstract][Full Text] [Related]
17. Lycopene inhibits PDGF-BB-induced signaling and migration in human dermal fibroblasts through interaction with PDGF-BB. Chiang HS; Wu WB; Fang JY; Chen DF; Chen BH; Huang CC; Chen YT; Hung CF Life Sci; 2007 Nov; 81(21-22):1509-17. PubMed ID: 17950366 [TBL] [Abstract][Full Text] [Related]
18. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling. Waltenberger J; Uecker A; Kroll J; Frank H; Mayr U; Bjorge JD; Fujita D; Gazit A; Hombach V; Levitzki A; Böhmer FD Circ Res; 1999 Jul; 85(1):12-22. PubMed ID: 10400906 [TBL] [Abstract][Full Text] [Related]
19. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells. Yeh CH; Peng HC; Yang RS; Huang TF Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719 [TBL] [Abstract][Full Text] [Related]
20. Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis. Yang GW; Jiang JS; Lu WQ Int J Mol Sci; 2015 Oct; 16(10):24011-31. PubMed ID: 26473837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]